Cardiac PET/CT is an evolving, non-invasive imaging modality that impacts patient management in many clinical scenarios. Beyond offering the capability to assess myocardial perfusion, inflammatory cardiac pathologies, and myocardial viability, cardiac PET/CT also allows for the non-invasive quantitative assessment of myocardial blood flow (MBF) and myocardial flow reserve (MFR). Recognizing the need for an enhanced comprehension of coronary physiology, Siemens Healthineers implemented a sophisticated solution for the calculation of MBF and MFR in 2009. As a result, each aspect of their innovative scanner and image-processing technology seamlessly integrates into an efficient, easy-to-use workflow for everyday clinical use that maximizes the number of patients who potentially benefit from this imaging modality.
CITATION STYLE
Bendriem, B., Reed, J., McCullough, K., Khan, M. R., Smith, A. M., Thomas, D., & Long, M. (2018). The continual innovation of commercial PET/CT solutions in nuclear cardiology: Siemens Healthineers. Journal of Nuclear Cardiology, 25(4), 1400–1411. https://doi.org/10.1007/s12350-018-1262-3
Mendeley helps you to discover research relevant for your work.